Future landscape for the management of membranous nephropathy

Amongall glomerular diseases, membranous nephropathy (MN) is perhaps the one in which major progress has been made in recent decades, in both the understanding of the pathogenesis and treatment. Despite the overall significant response rates to these therapies—particularly rituximab and cyclical reg...

Full description

Bibliographic Details

Main Author:	Caravaca-Fontán, Fernando (author)
Other Authors:	Yandian, Federico (author), Fervenza, Fernando C. (author)
Format:	article
Language:	English
Published:	2023
Subjects:	Belimumab Felzartamab Iptacopan Obinutuzumab Resistant membranous nephropathy ENFERMEDADES RENALES TERAPÉUTICA CORTICOESTEROIDES CICLOFOSAMIDA NANOPARTÍCULAS
Online Access:	https://hdl.handle.net/20.500.12008/52238
Tags:	Add Tag No Tags, Be the first to tag this record!